688062 fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Mabwell (Shanghai) Bioscience Co., Ltd. engages in the research and development, production and sales of therapeutic biological products. Its main product is antibody drugs. Its platform covered antibody drug discovery, pharmaceutical development, quality research control and assurance, medical and clinical operations, and commercial base. The company was founded on May 12, 2017 and is headquartered in Shanghai, China.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
688062 does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future
Financial health
Financial position and solvency of the company